Technical Analysis for NOVN - Novan, Inc.

Grade Last Price % Change Price Change
grade F 0.4501 -1.79% -0.01
NOVN closed down 1.79 percent on Wednesday, February 26, 2020, on 83 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical NOVN trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -1.79%
Wide Bands Range Expansion -1.79%
Bearish Engulfing Bearish -13.89%
1,2,3 Retracement Bearish Bearish Swing Setup -13.89%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -13.89%
20 DMA Support Bullish -13.89%
Outside Day Range Expansion -13.89%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.
Medical Specialties Organ Systems Infectious Diseases Acne Product Candidates Acne Vulgaris Cutaneous Conditions Fungal Infections Inflammatory Skin Diseases Treatment Of Inflammatory Skin Diseases Wart

Is NOVN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.72
52 Week Low 0.41
Average Volume 672,618
200-Day Moving Average 2.11
50-Day Moving Average 1.17
20-Day Moving Average 0.50
10-Day Moving Average 0.48
Average True Range 0.07
ADX 37.61
+DI 17.11
-DI 35.79
Chandelier Exit (Long, 3 ATRs ) 0.45
Chandelier Exit (Short, 3 ATRs ) 0.63
Upper Bollinger Band 0.59
Lower Bollinger Band 0.40
Percent B (%b) 0.24
BandWidth 37.38
MACD Line -0.15
MACD Signal Line -0.20
MACD Histogram 0.0478
Fundamentals Value
Market Cap 7.19 Million
Num Shares 16 Million
EPS -4.08
Price-to-Earnings (P/E) Ratio -0.11
Price-to-Sales 129.29
Price-to-Book 8.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.48
Resistance 3 (R3) 0.49 0.48 0.48
Resistance 2 (R2) 0.48 0.47 0.48 0.47
Resistance 1 (R1) 0.46 0.47 0.46 0.46 0.47
Pivot Point 0.46 0.46 0.46 0.46 0.46
Support 1 (S1) 0.44 0.45 0.44 0.44 0.43
Support 2 (S2) 0.44 0.44 0.43 0.43
Support 3 (S3) 0.42 0.44 0.42
Support 4 (S4) 0.42